We studied the incidence of late-onset adrenal hyperplasia as a cause of hirsutism, its association with the major histocompatibility complex, and its clinical expression. Twenty-four of 400 women seen because of hirsutism were found to have late-onset adrenal hyperplasia, diagnosed on the basis of a high plasma level of 17-hydroxyprogesterone, and its marked increase after ACTH stimulation. The degree of hirsutism varied widely. Plasma antigen levels were high, especially the level of androstenedione, whereas 5 alpha-reductase activity, considered to be a good index of peripheral androgen utilization, showed frequent normal or low values. The 24 patients were genotyped, along with 84 family members, and plasma hormones were measured in the family members. We found a high correlation between late-onset adrenal hyperplasia and HLA antigens B14 and Aw33. Similar biologic profiles were observed in the patients and those of their siblings who were HLA identical (n = 9), confirming that late-onset adrenal hyperplasia is linked to the histocompatibility complex. These nine siblings had no hirsutism. We therefore conclude that the role of skin sensitivity to androgens is important in determining the clinical expression of this disorder.

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJM198507253130404DOI Listing

Publication Analysis

Top Keywords

late-onset adrenal
20
adrenal hyperplasia
20
hyperplasia hirsutism
8
histocompatibility complex
8
clinical expression
8
family members
8
late-onset
5
hyperplasia
5
hirsutism
5
hirsutism studied
4

Similar Publications

Article Synopsis
  • * Research shows that this treatment can lower mortality rates, improve chances of survival without BPD, and support heart function and urine output, but there are concerns about risks like intestinal perforation and late-onset infections, especially in very premature infants.
  • * While long-term developmental outcomes appear unaffected, ongoing discussions focus on the ideal patient population, timing, duration of treatment, and obstacles to applying this treatment as guidelines evolve.
View Article and Find Full Text PDF

Secondary CNS involvement (SCNSL) is a rare manifestation of diffuse large B-cell lymphoma (DLBCL) with a poor prognosis. We present updated data from a nationwide study on the incidence and clinical characteristics of SCNSL. The incidence of SCNSL was calculated considering death or relapse without SCNSL as competing risks.

View Article and Find Full Text PDF

Aim: Despite the high sensitivity of neonatal screening in detecting the classical form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, one of the unclear issues is identifying asymptomatic children with late onset forms. The aim of this nationwide study was to analyse the association between genotype and screened level of 17-hydroxyprogesterone in patients with the late onset form of 21-hydroxylase deficiency and to quantify false negativity.

Methods: In the Czech Republic, 1,866,129 neonates were screened (2006-2022).

View Article and Find Full Text PDF
Article Synopsis
  • PI3K is involved in immune function, and defects in the PI3K/AKT/mTOR pathway lead to issues like recurrent infections, autoimmunity, and abnormal immune cell proliferation.
  • The study analyzed 12 patients with different PIK3 variants, revealing a long diagnostic delay and common symptoms such as respiratory infections and autoimmune issues in those with activated PI3K delta syndrome (APDS).
  • Molecular genetic analysis is essential for accurate diagnosis of these immune defects, as laboratory findings can help distinguish between APDS and other conditions related to immune dysregulation.
View Article and Find Full Text PDF

Objective: We studied the temporal course of hypothalamic-pituitary-adrenal (HPA) dysfunction in patients with coronavirus disease 2019 (COVID-19).

Methods: Three hundred and two patients (median age 54 years (interquartile range (IQR) 42-64), 76% males) were recruited. The HPA axis was evaluated by morning cortisol and adrenocorticotrophic hormone (ACTH) at admission (n = 232).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!